Clinical Trial Detail

NCT ID NCT03579888
Title CD19-Specific T Cells Post AlloSCT
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

CLL/SLL

chronic lymphocytic leukemia

acute lymphoblastic leukemia

Therapies

CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cells + Cyclophosphamide + Fludarabine

Age Groups: adult senior

No variant requirements are available.